GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 1 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,372,354 | -11.8% | 797,880 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,555,866 | +364.3% | 797,880 | +562.0% | 0.00% | +200.0% |
| Q1 2023 | $335,065 | -19.4% | 120,527 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $415,818 | +34.1% | 120,527 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $310,000 | +6.2% | 120,527 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $292,000 | -49.6% | 120,527 | -14.2% | 0.00% | 0.0% |
| Q1 2022 | $579,000 | -68.0% | 140,527 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $1,807,000 | +66.5% | 140,527 | +39.8% | 0.00% | +50.0% |
| Q3 2021 | $1,085,000 | -64.5% | 100,500 | -70.0% | 0.00% | -66.7% |
| Q2 2021 | $3,056,000 | -3.2% | 334,636 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $3,156,000 | +137.1% | 334,636 | -1.0% | 0.01% | +133.3% |
| Q4 2020 | $1,331,000 | +61.9% | 337,891 | +9.0% | 0.00% | +50.0% |
| Q3 2020 | $822,000 | -81.6% | 309,853 | -54.0% | 0.00% | -83.3% |
| Q2 2020 | $4,468,000 | +119.6% | 672,917 | +92.5% | 0.01% | +71.4% |
| Q1 2020 | $2,035,000 | -39.4% | 349,516 | -6.6% | 0.01% | -22.2% |
| Q4 2019 | $3,357,000 | – | 374,376 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $9,152,000 | 15.60% |
| Frazier Life Sciences Management, L.P. | 5,237,348 | $13,460,000 | 1.04% |
| Redmile Group, LLC | 6,952,760 | $17,869,000 | 0.69% |
| Palo Alto Investors LP | 2,330,504 | $5,989,000 | 0.47% |
| ACT CAPITAL MANAGEMENT, LLC | 47,500 | $122,000 | 0.17% |
| SkyOak Wealth, LLC | 132,851 | $341,000 | 0.12% |
| Artal Group S.A. | 750,000 | $1,928,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 77,046 | $198,000 | 0.04% |
| CAXTON ASSOCIATES LP | 95,190 | $245,000 | 0.03% |
| XTX Topco Ltd | 50,517 | $130,000 | 0.03% |